Normal skin microbiota is altered in pre-clinical hidradenitis suppurativa

Acta Dermato-Venereologica

Volumn 97, Issue 2, 2017, Pages 208-213

  Ring, Hans Christian ^a   Bay, Lene ^b   Kallenbach, Klaus ^a   Miller, Iben M ^a   Prens, Errol ^c   Saunte, Ditte M ^a   Bjarnsholt, Thomas ^b   Jemec, Gregor B E ^a  

^a ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biofilm; Hidradenitis suppurativa; Microbiota; Preclinical

Indexed keywords

PEPTIDE NUCLEIC ACID; RESORCINOL; RIBOSOME RNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL WALL; CLINICAL ARTICLE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN FLORA; SUPPURATIVE HIDRADENITIS; THERMOSTABILITY; ADOLESCENT; AXILLA; BIOFILM; BIOPSY; CONFOCAL MICROSCOPY; DIAGNOSTIC IMAGING; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PATHOLOGY; SKIN; YOUNG ADULT;

ADOLESCENT; ADULT; AXILLA; BIOFILMS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROBIOTA; MICROSCOPY, CONFOCAL; MIDDLE AGED; SKIN; YOUNG ADULT;

EID: 85011990221     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2503     Document Type: Article

References (44)

1. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012; 366: 158–164.
2. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191–194.
3. Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170: 884–889.
4. Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol 2015; 73: S4–S7.
5. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013; 133: 97–103.
6. Guet-Revillet H, Coignard-Biehler H, Jais JP, Quesne G, Frapy E, Poiree S, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis 2014; 20: 1990–1998.
7. Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A. Bacteriology of hidradenitis suppurativa/acne inversa: a review. J Am Acad Dermatol 2015; 73: S12–S18.
8. Ring HC, Riis MP, Miller IM, Jenssen H, Fuursted K, Saunte DM, et al. The bacteriology of hidradenitis suppurativa: a systematic review. Exp Dermatol 2015; 24: 727–731.
9. Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol 2011; 672: 1–8.
10. Blok JL, Janse IC, Horvath B, Jonkman MF. Increased expression of integrin alpha6beta4 in the basement membrane zone lining the sebaceous glands in hidradenitis suppurativa. Acta Derm Venereol 2015; 95: 994–996.
11. Hotz C, Boniotto M, Guguin A, Surenaud M, Jean-Louis F, Tisserand P, et al. Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis suppurativa. J Invest Dermatol 2016 May 17. [Epub ahead of print].
12. Giamarellos-Bourboulis EJ, Platzer M, Karagiannidis I, Kanni T, Nikolakis G, Ulrich J, et al. High copy numbers of betadefensin cluster on 8p23.1 confer genetic susceptibility and modulate the physical course of hidradenitis suppurativa/acne inversa. J Invest Dermatol 2016 May 6. [Epub ahead of print].
13. Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 2012; 166: 879–883.
14. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 1999; 140: 90–95.
15. Brook I, Frazier EH. Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol 1999; 48: 103–105.
16. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology 1996; 193: 203–206.
17. Matusiak L, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa – which antibiotics are the treatment of choice? Acta Derm Venereol 2014; 94: 699–702.
18. Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J 2012; 9: 14–32.
19. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167–193.
20. Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009; 17: 354–359.
21. Wolcott R. Disrupting the biofilm matrix improves wound healing outcomes. J Wound Care 2015; 24: 366–371.
22. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2–10.
23. Hogsberg T, Bjarnsholt T, Thomsen JS, Kirketerp-Moller K. Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: a retrospective study. PLoS One 2011; 6: e20492.
24. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619–644.
25. Jahns AC, Killasli H, Nosek D, Lundskog B, Lenngren A, Muratova Z, et al. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS 2014; 122: 804–809.
26. Kathju S, Lasko LA, Stoodley P. Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol 2012; 65: 385–389.
27. Fazli M, Bjarnsholt T, Hoiby N, Givskov M, Tolker-Nielsen T. PNA-based fluorescence in situ hybridization for identification of bacteria in clinical samples. Methods Mol Biol 2014; 1211: 261–271.
28. Bjarnsholt T, Alhede M, Alhede M, Eickhardt-Sorensen SR, Moser C, Kuhl M, et al. The in vivo biofilm. Trends Microbiol 2013; 21: 466–474.
29. Kragh KN, Alhede M, Jensen PO, Moser C, Scheike T, Jacobsen CS, et al. Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Infect Immun 2014; 82: 4477–4486.
30. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS 2013; Suppl 136: 1–51.
31. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen A, Andersen CB, Givskov M, et al. Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds. Wound Repair Regen 2011; 19: 387–391.
32. Homoe P, Bjarnsholt T, Wessman M, Sorensen HC, Johansen HK. Morphological evidence of biofilm formation in Green-landers with chronic suppurative otitis media. Eur Arch Otorhinolaryngol 2009; 266: 1533–1538.
33. Jahns AC, Oprica C, Vassilaki I, Golovleva I, Palmer RH, Alexeyev OA. Simultaneous visualization of Propionibacterium acnes and Propionibacterium granulosum with immunofluorescence and fluorescence in situ hybridization. Anaerobe 2013; 23: 48–54.
34. Jahns AC, Lundskog B, Berg J, Jonsson R, McDowell A, Patrick S, et al. Microbiology of folliculitis: a histological study of 39 cases. APMIS 2014; 122: 25–32.
35. Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 2009; 155: 2603–2611.
36. Leyden JJ, McGinley KJ, Nordstrom KM, Webster GF. Skin microflora. J Invest Dermatol 1987; 88: 65s–72s.
37. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 2011; 131: 1974–1980.
38. Volz T, Skabytska Y, Guenova E, Chen KM, Frick JS, Kirschning CJ, et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 2014; 134: 96–104.
39. Hanski I, von HL, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci USA 2012; 109: 8334–8339.
40. Lai Y, Di NA, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009; 15: 1377–1382.
41. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, et al. Compartmentalized control of skin immunity by resident commensals. Science 2012; 337: 1115–1119.
42. Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 2010; 130: 192–200.
43. Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012; 12: 496–508.
44. Callewaert C, Hutapea P, Van de Wiele T, Boon N. Deodorants and antiperspirants affect the axillary bacterial community. Arch Dermatol Res 2014; 306: 701–710.